Shanghai--(Business Wire)--The Health Industry Summit (tHIS) 2019, organized by Reed Sinopharm, will upgrade its scale to an exhibition area of 400,000 square meters and for the first time be split as two parts, namely China International Medicinal Equipment Fair (CMEF) and PharmChina to be held at the National Convention and Exhibition Center (Shanghai) on May 13-17, and API China – China’s leading exhibition for the pharmaceutical manufacturing sector – to be held at the Hangzhou International Expo Center on May 8-10.

This year, tHIS 2019 will both showcase products and technologies and promote trade and communication in the whole health industry. Moreover, during the nearly 10-day summit, more than 130 activities will be held, fully demonstrating its role as a trend-setter for the future health technologies. tHIS 2019 is expected to attract more than 7,400 exhibitors from more than 30 countries and regions, as well as 230,000 visitors from 150 countries.

The 81st CMEF will partner with the 2019 China Smart Health Exhibition and the 28th International Component Manufacturing & Design Show (ICMD) to cover the full industrial chain including medical equipment and medical technologies.

The 81st PharmChina will also launch various activities such as innovation forum, marketing forum, pharmaceutical agent meeting to help insiders boost their competitiveness in the rapidly changing Chinese pharmaceutical market.

API China (Hangzhou), as a renowned display and business platform covering the full industrial chain and full life cycle of China’s pharmaceutical industry, will work with leading pharmaceutical companies to promote pharmaceutical technology innovation and product upgrade in China.

Major exhibitors will include Mindray, Shinva, United Imaging, GE, Siemens, Philips, Yuyue, JD.COM, Omron, Foxconn, Intel, as well as major pharmaceutical groups in China such as Sinopharm, Shanghai Pharma and CR Pharmaceuticals.

As the most influential event in the global health industry, tHIS has been committed to providing global customers with all-round support in the Chinese market and maintaining the linkage between the global market and the Chinese market. Each year, it witnesses the advance of global health technology innovation and sheds light on the direction of the health industry.